<DOC>
	<DOCNO>NCT02128191</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety treatment compare ibuprofen treatment patent ductus arteriosus preterm infant . The study hypothesis treatment inferior oral ibuprofen treatment preterm infant . ( non-inferiority study )</brief_summary>
	<brief_title>No Treatment Versus Oral Ibuprofen Treatment Patent Ductus Arteriosus Preterm Infants</brief_title>
	<detailed_description>This study randomize , double-blind , placebo-controlled , non-inferiority clinical trial .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1. gestational age 30 week less birth weight 1250 g le 2. born Samsung Medical Center 3. confirm hemodynamically significant patent ductus arteriosus ( PDA ) day life ( DOL ) 5 14 4 . Definition hemodynamically significant PDA : least one clinical criterion plus least one echocardiographic criterion Clinical criterion Respiratory sign , include tachypnea , chest retraction , increase respiratory support , unable wean respiratory support Physical sign , include murmur , hyperdynamic precordium bounding pulse Blood pressure problem , include decrease mean diastolic pressure increase pulse pressure Signs congestive heart failure , include cardiomegaly , hepatomegaly pulmonary congestion Echocardiographic criterion Ductal size ≥ 1.5 mm leave atrium ( LA ) /Aorta ratio ≥1.5:1 Lefttoright shunt bidirectional shunting dominant lefttoright blood flow ( presence color jet mean pulmonary artery ) Mortality within first 48 hour life Righttoleft shunt bidirectional shunting dominant righttoleft shunt PDA congenital anomaly bilateral intraventricular hemorrhage grade 4 contraindication ibuprofen ( bleed diasthesis , platelet count 10,000/mm3 less , serum creatinine 2.0 mg/dL great , necrotizing enterocolitis stage 2 great</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
</DOC>